JMI LABS IS NOW PART OF LEARN MORE

In vitro activity of tigecycline, a new glycylcycline, tested against 1,326 clinical bacterial strains isolated from Latin America. by Gales AC, Jones RN, Andrade SS, Pereira AS and Sader HS published in Braz. J. Infect. Dis. 2005; 9 (5): 348-356

View publication